In comparison to 10% to 15% of adults who present with nephrotic syndrome, it accounts for 70% to 90% of children who are older than one-year-old and present with nephrotic syndrome. The hallmark of MCD is proteinuria, which causes edema & intravascular volume loss and has a positive reaction to steroids.
There are other names for MCD, including “nil disease,” “lipoid nephrosis,” & “minimal change lesion” (a description of the light-microscopy-detailed lipid droplets in urine). Pediatric patients with MCD have a relatively favorable prognosis.
Epidemiology
There are 2 to 7 new infections of MCD for every 100,000 kids. Although the actual frequency is unknown, it is assumed to be between 10 and 50 instances per 100,000 kids.
Throughout childhood, there is a 2 to the 1-male-to-female ratio that vanishes around adolescence. Adults do not frequently develop MCD, and the actual incidence is unknown.
Anatomy
Pathophysiology
When the GFB (glomerular filtration barrier) is damaged, the nephrotic syndrome of MCD manifests with increased renal membrane permeability and protein loss (mainly albumin). The GFB is made up of three layers: an inner layer of fenestrated endothelium, a middle layer of the glomerular basement membrane, and an external layer of podocyte-filled epithelium.
Podocytes are parallel-running epithelial cells that line the exterior of capillary walls and also have large cell bodies & lengthy foot processes. Slit diaphragms, a type of cell-to-cell connection, are found between each foot region. Both size and charge play a role in glomerular clearance. By controlling flow across the basal layer in response to the molecular charge, hydrostatic pressures, and molecule size, the actin cytoskeleton of podocytes supports the GBM.
The sialoglycoprotein (podocalyxin) that coats the apical & luminal layer of the slit diaphragms & podocytes helps to resist negative charge substances like albumin. Heparin sulphate proteoglycans make up the two outermost layers of the glomerular filtration barrier, which are also negatively charged and aid in the charge preference of the barrier. This barrier’s disruption causes the proteinuria present in nephrotic syndrome.
MCD is assumed to have a complex etiology, albeit this is only partially known. The integrity & biology of podocytes has received much attention in studies. A series of interactions govern the regulation of flow across the basement membrane because the actin cytoskeleton of podocytes upholds the cell body & foot processes, ensuring the stability of the podocytes.
The reason for proteinuria in MCD has thus been the subject of numerous theories. Some of the explanations put out in the literature include systemic circulating substances that impair podocyte function, T cell dysfunction/dysregulation that results in cytokine production & overexpression of proteins like CD80 & C-MIP that alter the stability of podocytes, and B cell activation (suspected due to the efficacy of anti- CD-20 monoclonal autoantibodies, like rituximab).
Etiology
The basic cause of the illness is idiopathic, but it can develop later after exposure to different agents:
Other glomerular illness: Associated with SLE, type 1 DM, IgA nephropathy, & HIV
Genetics
Prognostic Factors
If there is a reaction to corticosteroid treatment, MCD has a very favorable prognosis for patients of all ages. The side effects of the drugs are the main cause of morbidity.
Clinical History
Clinical History
First, facial edema is noticed. An upper RTI, an allergic response to a bee sting, the use of specific medicines, or cancer may precede edema. Malaise & sluggish fatigability are possible. Often, excess weight is an added characteristic.
Additionally, the patient could display any of the following:
Infection
Thromboembolism
Hypertension
Hypovolemia
Physical Examination
Physical Examination
In youngsters, blood pressure is often normal, although, in adults, it may be raised. (Additionally, individuals frequently have modestly increased plasma creatinine levels at presentation.)
The most noticeable symptom is dependency edema. The retina appears to be moist. Muehrcke lines, or subungual edema with horizontal lines, can also happen.
Ear elasticity may be affected, and hernias may be discovered. A state of protein depletion with muscular atrophy, thinning skin, & growth failure results from persistently high proteinuria.
Fluid can build up in the pleura & ascites. Rarely, the first sign of an underlining nephrotic disease may be peritonitis, cellulitis, and pneumonia.
Lymphatic: Congenital lymphedema, Primary and secondary lymphedema
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
Steroids are the first and foremost treatment for MCD. Compared to adults, who often take steroids for two months or longer, children frequently experience remission within four weeks. Relapse frequently occurs in both adults and children.
Children
Early prednisone treatment is either a daily dose of 60 mg/m2 (or 2 mg/kg) for 4-6 weeks (60 mg/day as a maximum dose) or a taper of 40 mg/m2 (as well as 1.5 mg/kg) on alternate days for 2 to 5 months. For a minimum of 12 weeks, reduce the dosage by 5 mg/m2 – 10 mg/m2 every week for an additional 4 weeks, then discontinue.
Adults
Prednisone is first prescribed in doses of 1 mg per kg per day or 2 mg per kg per day (maximum 80 mg per day or 120 mg every other day) for a period of 4 to 16 weeks. After remission, gradually reduce the dosage over a period of six months.
Individuals with Relapse Show off the following.
The recurrence of proteinuria in adolescents after four weeks of prednisone and also in adults after sixteen weeks is a sign of steroid sensitivity.
Relapses are frequent and are defined as two or more in the first six months of presentation or 4 or more in any one year.
Relapses that take place during the tapering period of steroid treatment or less than 2 weeks after stopping steroids are seen as signs of steroid dependence.
Reoccurrence nephrosis: > 2+ proteinuria for three days in a row
If there is a recurrence, prednisolone should be continued at 2 mg/kg daily (maximum 60 mg) for 3 days until relapse, then 1.5 mg/kg odd days for four weeks, discontinue or reduce the dose over 4 to 8 weeks.
For recurrent episodes or steroid dependence (steroid-sparing agents)
Cyclosporine: 4 – 5 mg/kg/day, typically for 1 to 2 years. After one to two weeks, levels need to be checked. Plan on a trough between 70 and 150. can result in gingival hyperplasia, hirsutism, nephrotoxicity, & hypertension.
Cyclophosphamide: possible alopecia, gonadal toxicity & bone marrow suppression at a dose of 2 mg/kg/day for eight to twelve weeks (should be begun after reaching relapse with the steroid).
If unable to take the aforementioned medications, administer:
Rituximab (chimeric monoclonal autoantibody): 375 mg in 1 to 4 dosages every week. Symptoms like deadly Pneumocystis jirovecii infections, fulminant myocarditis, pulmonary fibrosis, ulcerative colitis, & allergic responses.
In comparison to 10% to 15% of adults who present with nephrotic syndrome, it accounts for 70% to 90% of children who are older than one-year-old and present with nephrotic syndrome. The hallmark of MCD is proteinuria, which causes edema & intravascular volume loss and has a positive reaction to steroids.
There are other names for MCD, including “nil disease,” “lipoid nephrosis,” & “minimal change lesion” (a description of the light-microscopy-detailed lipid droplets in urine). Pediatric patients with MCD have a relatively favorable prognosis.
There are 2 to 7 new infections of MCD for every 100,000 kids. Although the actual frequency is unknown, it is assumed to be between 10 and 50 instances per 100,000 kids.
Throughout childhood, there is a 2 to the 1-male-to-female ratio that vanishes around adolescence. Adults do not frequently develop MCD, and the actual incidence is unknown.
When the GFB (glomerular filtration barrier) is damaged, the nephrotic syndrome of MCD manifests with increased renal membrane permeability and protein loss (mainly albumin). The GFB is made up of three layers: an inner layer of fenestrated endothelium, a middle layer of the glomerular basement membrane, and an external layer of podocyte-filled epithelium.
Podocytes are parallel-running epithelial cells that line the exterior of capillary walls and also have large cell bodies & lengthy foot processes. Slit diaphragms, a type of cell-to-cell connection, are found between each foot region. Both size and charge play a role in glomerular clearance. By controlling flow across the basal layer in response to the molecular charge, hydrostatic pressures, and molecule size, the actin cytoskeleton of podocytes supports the GBM.
The sialoglycoprotein (podocalyxin) that coats the apical & luminal layer of the slit diaphragms & podocytes helps to resist negative charge substances like albumin. Heparin sulphate proteoglycans make up the two outermost layers of the glomerular filtration barrier, which are also negatively charged and aid in the charge preference of the barrier. This barrier’s disruption causes the proteinuria present in nephrotic syndrome.
MCD is assumed to have a complex etiology, albeit this is only partially known. The integrity & biology of podocytes has received much attention in studies. A series of interactions govern the regulation of flow across the basement membrane because the actin cytoskeleton of podocytes upholds the cell body & foot processes, ensuring the stability of the podocytes.
The reason for proteinuria in MCD has thus been the subject of numerous theories. Some of the explanations put out in the literature include systemic circulating substances that impair podocyte function, T cell dysfunction/dysregulation that results in cytokine production & overexpression of proteins like CD80 & C-MIP that alter the stability of podocytes, and B cell activation (suspected due to the efficacy of anti- CD-20 monoclonal autoantibodies, like rituximab).
The basic cause of the illness is idiopathic, but it can develop later after exposure to different agents:
Other glomerular illness: Associated with SLE, type 1 DM, IgA nephropathy, & HIV
If there is a reaction to corticosteroid treatment, MCD has a very favorable prognosis for patients of all ages. The side effects of the drugs are the main cause of morbidity.
Clinical History
First, facial edema is noticed. An upper RTI, an allergic response to a bee sting, the use of specific medicines, or cancer may precede edema. Malaise & sluggish fatigability are possible. Often, excess weight is an added characteristic.
Additionally, the patient could display any of the following:
Infection
Thromboembolism
Hypertension
Hypovolemia
Physical Examination
In youngsters, blood pressure is often normal, although, in adults, it may be raised. (Additionally, individuals frequently have modestly increased plasma creatinine levels at presentation.)
The most noticeable symptom is dependency edema. The retina appears to be moist. Muehrcke lines, or subungual edema with horizontal lines, can also happen.
Ear elasticity may be affected, and hernias may be discovered. A state of protein depletion with muscular atrophy, thinning skin, & growth failure results from persistently high proteinuria.
Fluid can build up in the pleura & ascites. Rarely, the first sign of an underlining nephrotic disease may be peritonitis, cellulitis, and pneumonia.
Lymphatic: Congenital lymphedema, Primary and secondary lymphedema
Steroids are the first and foremost treatment for MCD. Compared to adults, who often take steroids for two months or longer, children frequently experience remission within four weeks. Relapse frequently occurs in both adults and children.
Children
Early prednisone treatment is either a daily dose of 60 mg/m2 (or 2 mg/kg) for 4-6 weeks (60 mg/day as a maximum dose) or a taper of 40 mg/m2 (as well as 1.5 mg/kg) on alternate days for 2 to 5 months. For a minimum of 12 weeks, reduce the dosage by 5 mg/m2 – 10 mg/m2 every week for an additional 4 weeks, then discontinue.
Adults
Prednisone is first prescribed in doses of 1 mg per kg per day or 2 mg per kg per day (maximum 80 mg per day or 120 mg every other day) for a period of 4 to 16 weeks. After remission, gradually reduce the dosage over a period of six months.
Individuals with Relapse Show off the following.
The recurrence of proteinuria in adolescents after four weeks of prednisone and also in adults after sixteen weeks is a sign of steroid sensitivity.
Relapses are frequent and are defined as two or more in the first six months of presentation or 4 or more in any one year.
Relapses that take place during the tapering period of steroid treatment or less than 2 weeks after stopping steroids are seen as signs of steroid dependence.
Reoccurrence nephrosis: > 2+ proteinuria for three days in a row
If there is a recurrence, prednisolone should be continued at 2 mg/kg daily (maximum 60 mg) for 3 days until relapse, then 1.5 mg/kg odd days for four weeks, discontinue or reduce the dose over 4 to 8 weeks.
For recurrent episodes or steroid dependence (steroid-sparing agents)
Cyclosporine: 4 – 5 mg/kg/day, typically for 1 to 2 years. After one to two weeks, levels need to be checked. Plan on a trough between 70 and 150. can result in gingival hyperplasia, hirsutism, nephrotoxicity, & hypertension.
Cyclophosphamide: possible alopecia, gonadal toxicity & bone marrow suppression at a dose of 2 mg/kg/day for eight to twelve weeks (should be begun after reaching relapse with the steroid).
If unable to take the aforementioned medications, administer:
Rituximab (chimeric monoclonal autoantibody): 375 mg in 1 to 4 dosages every week. Symptoms like deadly Pneumocystis jirovecii infections, fulminant myocarditis, pulmonary fibrosis, ulcerative colitis, & allergic responses.
In comparison to 10% to 15% of adults who present with nephrotic syndrome, it accounts for 70% to 90% of children who are older than one-year-old and present with nephrotic syndrome. The hallmark of MCD is proteinuria, which causes edema & intravascular volume loss and has a positive reaction to steroids.
There are other names for MCD, including “nil disease,” “lipoid nephrosis,” & “minimal change lesion” (a description of the light-microscopy-detailed lipid droplets in urine). Pediatric patients with MCD have a relatively favorable prognosis.
There are 2 to 7 new infections of MCD for every 100,000 kids. Although the actual frequency is unknown, it is assumed to be between 10 and 50 instances per 100,000 kids.
Throughout childhood, there is a 2 to the 1-male-to-female ratio that vanishes around adolescence. Adults do not frequently develop MCD, and the actual incidence is unknown.
When the GFB (glomerular filtration barrier) is damaged, the nephrotic syndrome of MCD manifests with increased renal membrane permeability and protein loss (mainly albumin). The GFB is made up of three layers: an inner layer of fenestrated endothelium, a middle layer of the glomerular basement membrane, and an external layer of podocyte-filled epithelium.
Podocytes are parallel-running epithelial cells that line the exterior of capillary walls and also have large cell bodies & lengthy foot processes. Slit diaphragms, a type of cell-to-cell connection, are found between each foot region. Both size and charge play a role in glomerular clearance. By controlling flow across the basal layer in response to the molecular charge, hydrostatic pressures, and molecule size, the actin cytoskeleton of podocytes supports the GBM.
The sialoglycoprotein (podocalyxin) that coats the apical & luminal layer of the slit diaphragms & podocytes helps to resist negative charge substances like albumin. Heparin sulphate proteoglycans make up the two outermost layers of the glomerular filtration barrier, which are also negatively charged and aid in the charge preference of the barrier. This barrier’s disruption causes the proteinuria present in nephrotic syndrome.
MCD is assumed to have a complex etiology, albeit this is only partially known. The integrity & biology of podocytes has received much attention in studies. A series of interactions govern the regulation of flow across the basement membrane because the actin cytoskeleton of podocytes upholds the cell body & foot processes, ensuring the stability of the podocytes.
The reason for proteinuria in MCD has thus been the subject of numerous theories. Some of the explanations put out in the literature include systemic circulating substances that impair podocyte function, T cell dysfunction/dysregulation that results in cytokine production & overexpression of proteins like CD80 & C-MIP that alter the stability of podocytes, and B cell activation (suspected due to the efficacy of anti- CD-20 monoclonal autoantibodies, like rituximab).
The basic cause of the illness is idiopathic, but it can develop later after exposure to different agents:
Other glomerular illness: Associated with SLE, type 1 DM, IgA nephropathy, & HIV
If there is a reaction to corticosteroid treatment, MCD has a very favorable prognosis for patients of all ages. The side effects of the drugs are the main cause of morbidity.
Clinical History
First, facial edema is noticed. An upper RTI, an allergic response to a bee sting, the use of specific medicines, or cancer may precede edema. Malaise & sluggish fatigability are possible. Often, excess weight is an added characteristic.
Additionally, the patient could display any of the following:
Infection
Thromboembolism
Hypertension
Hypovolemia
Physical Examination
In youngsters, blood pressure is often normal, although, in adults, it may be raised. (Additionally, individuals frequently have modestly increased plasma creatinine levels at presentation.)
The most noticeable symptom is dependency edema. The retina appears to be moist. Muehrcke lines, or subungual edema with horizontal lines, can also happen.
Ear elasticity may be affected, and hernias may be discovered. A state of protein depletion with muscular atrophy, thinning skin, & growth failure results from persistently high proteinuria.
Fluid can build up in the pleura & ascites. Rarely, the first sign of an underlining nephrotic disease may be peritonitis, cellulitis, and pneumonia.
Lymphatic: Congenital lymphedema, Primary and secondary lymphedema
Steroids are the first and foremost treatment for MCD. Compared to adults, who often take steroids for two months or longer, children frequently experience remission within four weeks. Relapse frequently occurs in both adults and children.
Children
Early prednisone treatment is either a daily dose of 60 mg/m2 (or 2 mg/kg) for 4-6 weeks (60 mg/day as a maximum dose) or a taper of 40 mg/m2 (as well as 1.5 mg/kg) on alternate days for 2 to 5 months. For a minimum of 12 weeks, reduce the dosage by 5 mg/m2 – 10 mg/m2 every week for an additional 4 weeks, then discontinue.
Adults
Prednisone is first prescribed in doses of 1 mg per kg per day or 2 mg per kg per day (maximum 80 mg per day or 120 mg every other day) for a period of 4 to 16 weeks. After remission, gradually reduce the dosage over a period of six months.
Individuals with Relapse Show off the following.
The recurrence of proteinuria in adolescents after four weeks of prednisone and also in adults after sixteen weeks is a sign of steroid sensitivity.
Relapses are frequent and are defined as two or more in the first six months of presentation or 4 or more in any one year.
Relapses that take place during the tapering period of steroid treatment or less than 2 weeks after stopping steroids are seen as signs of steroid dependence.
Reoccurrence nephrosis: > 2+ proteinuria for three days in a row
If there is a recurrence, prednisolone should be continued at 2 mg/kg daily (maximum 60 mg) for 3 days until relapse, then 1.5 mg/kg odd days for four weeks, discontinue or reduce the dose over 4 to 8 weeks.
For recurrent episodes or steroid dependence (steroid-sparing agents)
Cyclosporine: 4 – 5 mg/kg/day, typically for 1 to 2 years. After one to two weeks, levels need to be checked. Plan on a trough between 70 and 150. can result in gingival hyperplasia, hirsutism, nephrotoxicity, & hypertension.
Cyclophosphamide: possible alopecia, gonadal toxicity & bone marrow suppression at a dose of 2 mg/kg/day for eight to twelve weeks (should be begun after reaching relapse with the steroid).
If unable to take the aforementioned medications, administer:
Rituximab (chimeric monoclonal autoantibody): 375 mg in 1 to 4 dosages every week. Symptoms like deadly Pneumocystis jirovecii infections, fulminant myocarditis, pulmonary fibrosis, ulcerative colitis, & allergic responses.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
